4.0
30 June 2025
Former employee, more than 1 year
Baar, Zug
Recommend
CEO approval
Business outlook
Pros
Adaptive approaches, using the best of every individual. Even more - helping to identify your best sides first.
Cons
Standard risks for small biotechs